In contrast to the observation in a previous study, we increased the sample size and surveyed the serum concentrations of CT-1 in subjects with NAFLD, and we found that the serum concentrations of CT-1 were negatively associated with CAP value after adjustment for confounding factors. The gene discussed is CTF1; the disease is metabolic dysfunction-associated steatotic liver disease.